Results 1 to 10 of about 1,159,242 (199)

Primary multidrug-resistant tuberculosis and its control implications in the State of Amazonas, Brazil: report of 3 cases

Revista da Sociedade Brasileira de Medicina Tropical, 2012
The occurrence of tuberculosis with first-line multidrug resistance leads to the use of alternative medications, often at higher costs, longer treatment periods, and greater clinical complexity.
Marlucia Silva Garrido, Anette Chrusciak Talhari, Irineide Assumpção Antunes, Joycenea da Silva Matsuda, Etelvina das Graças Zaranza, Flor Ernestina Martinez-Espinosa, Samira Bührer-Sékula   +6 more
doaj   +1 more source

Social aspects multi-drug resistant tuberculosis

Бюллетень сибирской медицины, 2012
The comparative analysis of features of clinical symptoms, spectrum and the importance of burdening medico-social factors of a tuberculosis of lungs with primary MDR М.
O. V. Filinyuk, O. I. Urazova, Ye. V. Nekrasov, L. N. Buinova, O. V. Kolokolova, I. G. Felker, O. Yu. Khristenko   +6 more
doaj   +1 more source

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone

Emerging Infectious Diseases, 2019
Resistance to second-line tuberculosis drugs for patients with multidrug-resistant tuberculosis has emerged globally and is a potential risk factor for unfavorable outcomes of shorter duration drug regimens.
Pravin K. Singh, Amita Jain
doaj   +1 more source

Hematological Profiles of Pulmonary Tuberculosis and Multi‐Drug‐Resistant Tuberculosis Patients at Debre Tabor Comprehensive Specialized Hospital, North‐Central Ethiopia: A Comparative Cross‐Sectional Study

Health Science Reports
Background and Aims Tuberculosis is a major infectious disease that affects hematological profiles. However, limited data assess changes in hematological profiles among patients with pulmonary and multidrug‐resistant tuberculosis.
Ayenew Berhan, Bekele Sharew, Andargachew Almaw, Shewaneh Damtie, Biruk Legese, Mulat Erkihun, Ayenew Assefa, Birhanemaskal Malkamu, Getu Abeje, Birhanu Getie, Yenealem Solomon   +10 more
doaj   +1 more source

Determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in Tigray Region, Ethiopia: a case–control study

BMJ Open Respiratory Research
Background Multidrug-resistant tuberculosis is a type of tuberculosis that is resistant to at least the first-line antituberculosis drugs namely, rifampicin and isoniazid. However, most of these studies were limited only to a single hospital.
Kidane Zereabruk, Tensay Kahsay, Hiyab Teklemichael, Woldu Aberhe, Abrha Hailay, Guesh Mebrahtom, Gebrewahd Bezabh   +6 more
doaj   +1 more source

A new roadmap for childhood tuberculosis

The Lancet Global Health, 2014
Colleen D Acosta, Valiantsin Rusovich, Anthony D Harries, Sevim Ahmedov, Martin van den Boom, Masoud Dara   +5 more
doaj   +1 more source

Relationship Between Substance Abuse and Multidrug-Resistant Tuberculosis

IMC Journal of Medical Science, 2012
This case control study was conducted between January to June 2010 to determine the relationship between substance abuse and multidrug- resistant tuberculosis.
Sadya Afroz, Meerjady Sabrina Flora
doaj  

Characteristics of Primary and acquired multidrug-resistant tuberculosis patients in West Java, Indonesia. [PDF]

IJID Reg
Santoso P, Khairani AP, Buchori E, Chaidir L, Soeroto AY.   +4 more
europepmc   +1 more source

Treatment of multidrug-resistant tuberculosis with bedaquiline, pretomanid, linezolid, and moxifloxacin following near-total gastrectomy. [PDF]

ASM Case Rep
Weheba I, Brode SK, Richard-Greenblatt M, Sabur NF.   +3 more
europepmc   +1 more source

Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era. [PDF]

Clin Infect Dis
Churchyard GJ, Swindells S, Gupta A, Shah NS, Hughes M, Kim S, Fox GJ, Harrington M, Chaisson RE, Hesseling AC.   +9 more
europepmc   +1 more source